Laurent Humeau is Chief Scientific Officer of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 32,622 shares of INO, which is worth approximately $64,265. The most recent transaction as insider was on Mar 08, 2021, when has been sold 19,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.6K
34.04% 3M change
34.04% 12M change
Total Value Held $64,265

Laurent Humeau Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2021
BUY
Exercise of conversion of derivative security
-
19,900 Added 24.2%
62,334 Common Stock
Mar 05 2021
SELL
Payment of exercise price or tax liability
$88,518 $9.19 p/Share
9,632 Reduced 18.5%
42,434 Common Stock
Mar 05 2021
BUY
Exercise of conversion of derivative security
-
27,566 Added 34.62%
52,066 Common Stock
Nov 10 2020
SELL
Open market or private sale
$189,794 $9.75 p/Share
19,466 Reduced 44.28%
24,500 Common Stock
LH

Laurent Humeau

Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on INO

Follow INOVIO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO